Evidence map›Paper›PMID 38192881›Full record

ArticleAdvanced biomedical research2023

Hypermethylation of

Sara Azhdari, Fatemeh Khodabandehloo, Naeim Ehtesham, Seyed Amirhossein Mazhari, Javad Behroozi, Goli Siri

Open access · goldAbstract read
In one paragraph

Article in Advanced biomedical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Sara AzhdariDepartment of Anatomy and Embryology, School of Medicine, Bam University of Medical Sciences, Bam, Iran.
Fatemeh KhodabandehlooMedical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran.
Naeim EhteshamSchool of Medicine, Iranshahr University of Medical Sciences, Irnshahr, Iran.
Seyed Amirhossein MazhariStudent Research Committee, Azerbaijan Medical University, Baku, Azerbaijan.
Javad BehrooziDepartment of Genetics and Advanced Medical Technology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Goli SiriDepartment of Internal Medicine, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Aja University of Medical Sciences · IRAzerbaijan Medical University · AZBam University of Medical Sciences · IRIranshahr University · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early colorectal cancer (CRC) diagnosis can drastically reduce CRC-related morbidity and mortality. In this regard, increasing attention is now being directed to DNA-based tests, especially the evaluation of methylation levels, to prioritize high-risk suspected persons for colonoscopy examination. Therefore, we aimed to assess the accuracy of Materials and Methods: For this study, a total of seventy individuals with CRC and 75 healthy individuals from Iran were included. The methylation level of Results: The mean promoter methylation level of Conclusion: Methylation evaluation of

Indexed as

Biomarkercolorectal cancermethylationMGMT

Identifiers

PMID38192881
PMCPMC10772801
OpenAlexW4390706239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.